Guerrero Ramiro's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Aug 2, 2022
- Accession no.
- 0000899243-22-027444
- Filed
- Aug 2, 2022
- Trade date
- Jul 28-Aug 1, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $136.0K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guerrero RamiroCIK 0001913253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2022 | Common Stock | PPurchaseAcquired | +9,000 | $4.00 | +$36,000 | 268,382 | Direct | |
| Aug 1, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $5.00 | +$100,000 | 288,382 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.